iSonea picks manufacturing partner for AirSonea
iSonea (ASX:ISN) has selected Hong Kong-based Refined Manufacturing to produce its AirSonea mobile wheeze monitoring device.
iSonea, which plans to launch the product in the Australian market in September, had already engaged Refined to produce several prototype AirSonea units. Refined will now scale up to prepare for commercial manufacturing.
“Finding a source with extensive experience and scalability to manufacture products that are smart-phone compatible was a crucial step in our transition to commercial production,” iSonea CEO Michael Thomas said.
AirSonea will allow patients to track and share acoustic respiratory monitoring data via smart phones.
Last week, iSonea released the results of a survey suggesting that 80% of Australian GPs surveyed would recommend AirSonea to their patients.
The company also recently unveiled AsthmaSense cloud, a cloud-based asthma monitoring tool.
iSonea shares were trading 8.11% higher at $0.40 as of around 1.30 pm on Wednesday.
Babies of stressed mothers likely to get their teeth earlier
Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...
Customised immune cells used to fight brain cancer
Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...
Elevated blood protein levels predict mortality
Proteins that play key roles in the development of diseases such as cancer and inflammation may...
